Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.

Neuron | Dec 24, 2009

The N-terminal 17 amino acids of huntingtin (NT17) can be phosphorylated on serines 13 and 16; however, the significance of these modifications in Huntington's disease pathogenesis remains unknown. In this study, we developed BAC transgenic mice expressing full-length mutant huntingtin (fl-mhtt) with serines 13 and 16 mutated to either aspartate (phosphomimetic or SD) or alanine (phosphoresistant or SA). Both mutant proteins preserve the essential function of huntingtin in rescuing knockout mouse phenotypes. However, fl-mhtt-induced disease pathogenesis, including motor and psychiatric-like behavioral deficits, mhtt aggregation, and selective neurodegeneration are abolished in SD but preserved in SA mice. Moreover, modification of these serines in expanded repeat huntingtin peptides modulates aggregation and amyloid fibril formation in vitro. Together, our findings demonstrate that serines 13 and 16 are critical determinants of fl-mhtt-induced disease pathogenesis in vivo, supporting the targeting of huntingtin NT17 domain and its modifications in HD therapy.

Pubmed ID: 20064390 RIS Download

Mesh terms: Alanine | Amino Acid Sequence | Amino Acid Substitution | Amyloid | Animals | Aspartic Acid | Disease Models, Animal | Gene Expression Regulation | Genetic Predisposition to Disease | Humans | Huntingtin Protein | Huntington Disease | Mice | Mice, Transgenic | Molecular Weight | Mutation | Nerve Degeneration | Nerve Tissue Proteins | Nuclear Proteins | Phenotype | Protein Structure, Tertiary | Serine | Trinucleotide Repeat Expansion

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: R01 NS049501-01
  • Agency: NINDS NIH HHS, Id: R01 NS049501
  • Agency: NINDS NIH HHS, Id: R01 NS049501-05S1
  • Agency: NINDS NIH HHS, Id: 2R01NS45491
  • Agency: NINDS NIH HHS, Id: R01 NS049501-05
  • Agency: NINDS NIH HHS, Id: R24 NS045491
  • Agency: NINDS NIH HHS, Id: R01 NS039074
  • Agency: NIA NIH HHS, Id: R01AG019322
  • Agency: NINDS NIH HHS, Id: R01NS049501
  • Agency: NINDS NIH HHS, Id: R01 NS049501-02
  • Agency: NINDS NIH HHS, Id: NS045283
  • Agency: NINDS NIH HHS, Id: 3R01NS049501-05S1
  • Agency: NINDS NIH HHS, Id: 2R01NS39074
  • Agency: NINDS NIH HHS, Id: R01 NS045283
  • Agency: NINDS NIH HHS, Id: R01 NS052789
  • Agency: NIA NIH HHS, Id: R01 AG019322
  • Agency: NINDS NIH HHS, Id: R01 NS049501-03
  • Agency: NIA NIH HHS, Id: P01 AG022074
  • Agency: NINDS NIH HHS, Id: NS52789
  • Agency: NINDS NIH HHS, Id: R01 NS049501-04
  • Agency: NIA NIH HHS, Id: 2P01AG022074

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.